Related Experiment Video
Updated: Aug 5, 2025

Creation of a Knee Joint-on-a-Chip for Modeling Joint Diseases and Testing Drugs
Published on: January 27, 2023
2-Styrylchromones Prevent IL-1β-Induced Pro-Inflammatory Activation of Fibroblast-like Synoviocytes while Increasing
Ana Teresa Rufino1, Mariana Lucas1, Artur M S Silva2
1LAQV, REQUIMTE, Laboratory of Applied Chemistry, Department of Chemical Sciences, Faculty of Pharmacy, University of Porto, Rua de Jorge Viterbo Ferreira No. 228, 4050-313 Porto, Portugal.
Abstract:
Rheumatoid arthritis (RA) is characterized by systemic immune and chronic inflammatory features, leading to the destruction of the joints. Presently, there are no effective drugs able to control synovitis and catabolism in the process of RA. 2-Styrylchromones (2-SC) are a small group of compounds characterized by the attachment of a styryl group to the chromone core that have already been associated to a wide range of biological activities, including antioxidant and anti-inflammatory activities. The present study investigated the effect of a set of six 2-SC on the interleukin-1β (IL-1β)-induced increase of nitric oxide (•NO), inducible form of nitric oxide synthase (iNOS), cyclooxygenase-2 (COX-2), and matrix metalloproteinase-3 (MMP-3) expression levels in human fibroblast-like synoviocytes (HFLS), pointing to the role of nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB) activation in the process. From a set of six 2-SC, presenting hydroxy and methoxy substituents, the one presenting two methoxy substituents at C-5 and C-7 of A ring and a catechol group on B ring, significantly reduced •NO production and the expression of its inducible synthase (iNOS). It also significantly reduced the catabolic MMP-3 protein expression. This 2-SC inhibited the NF-κB pathway by reversing the IL-1β - induced levels of cytoplasmatic NF-kB inhibitor alpha (IκBα), and decreasing the p65 nuclear levels, suggesting the involvement of these pathways in the observed effects. The same 2-SC significantly increased the COX-2 expression, which may indicate a negative feedback loop mechanism of action. The properties of 2-SC may be of great value in the development of new therapies with improved efficacy and selectivity towards RA, and thus deserve further exploitation and evaluation to disclose the full potential of 2-SC.
Insights
This study explored 2-Styrylchromones (2-SC) as potential treatments for rheumatoid arthritis (RA). One specific 2-SC compound effectively reduced inflammation markers and inhibited key pathways involved in RA joint destruction.
Area of Science:
- Biochemistry and Molecular Biology
- Immunology
- Pharmacology
Background:
- Rheumatoid arthritis (RA) is a chronic inflammatory disease causing joint destruction.
- Current RA treatments lack efficacy in controlling synovitis and catabolism.
- 2-Styrylchromones (2-SC) possess known antioxidant and anti-inflammatory properties.
Purpose of the Study:
- To investigate the anti-inflammatory and anti-catabolic effects of six 2-SC compounds on human fibroblast-like synoviocytes (HFLS).
- To elucidate the role of the nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB) pathway in the action of 2-SC.
Main Methods:
- Assessed the impact of 2-SC on interleukin-1β (IL-1β)-induced nitric oxide (NO), inducible nitric oxide synthase (iNOS), cyclooxygenase-2 (COX-2), and matrix metalloproteinase-3 (MMP-3) in HFLS.
- Analyzed the modulation of the NF-κB pathway, including inhibitor of kappa B alpha (IκBα) and p65 nuclear levels.
Main Results:
- One specific 2-SC compound significantly reduced NO production and iNOS expression.
- This 2-SC also decreased MMP-3 protein expression, indicating anti-catabolic effects.
- The compound inhibited the NF-κB pathway by affecting IκBα and p65 levels, while increasing COX-2 expression.
Conclusions:
- A specific 2-SC derivative demonstrates significant potential for treating RA by reducing inflammation and cartilage degradation.
- The compound's mechanism involves the inhibition of the NF-κB pathway.
- Further research into 2-SC compounds could lead to novel, effective RA therapies.
More Related Videos
Related Concept Videos
T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The...
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
TGF - β Signaling Pathway
The JAK-STAT Signaling Pathway
Inflammatory Response
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...

